Eric Singhi

Dr. Eric Singhi, a thoracic medical oncologist from MD Anderson, shares his expertise on treating EGFR-mutated non-small cell lung cancer. He delves into groundbreaking trials like MARIPOSA and FLAURA2, revealing essential insights into treatment strategies and patient management. The discussion includes real-life patient cases, the significance of repeat tissue profiling, and approaches to manage side effects. Singhi emphasizes the role of multidisciplinary teams and the need to understand resistance patterns for effective treatment planning.